CNBKA yields 11.17% · JNJ yields 2.13%● Live data
📍 CNBKA pulled ahead of the other in Year 1
Combined, CNBKA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNBKA + JNJ for your $10,000?
Century Bancorp, Inc. operates as a bank holding company for Century Bank and Trust Company that provides banking products and services. The company accepts savings accounts, NOW accounts, demand deposits, time deposits, and money market accounts, as well as cash management accounts. It offers single-family and multi-family residential loans, commercial and residential real estate loans, municipal loans, and various consumer loans, as well as provides loans for the construction of residential homes, multi-family properties, commercial real estate properties, and land development. The company also provides automated lockbox collection, cash management, and account reconciliation services to corporate and institutional customers, as well as to the municipal market; and securities brokerage services. It serves commercial enterprises, state and local governments and agencies, non-profit organizations, and individuals in Massachusetts, New Hampshire, Rhode Island, Connecticut, and New York. As of March 31, 2020, the company operated 27 banking offices in 20 cities and towns in Massachusetts. Century Bancorp, Inc. was founded in 1969 and is headquartered in Medford, Massachusetts.
Full CNBKA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.